Companies › ACAD

ACADIA PHARMACEUTICALS INC COM (ACAD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001070494 · EDGAR filings · Updated 2026-06-29

ACADIA PHARMACEUTICALS INC COM (ACAD) has reported institutional ownership of 96.2%, with 339 institutional managers holding positions valued at $3.67B per the latest 13F reporting period.

Latest updates

• 2026-06-29 — Insider transaction reported (Form 4)
• 2026-06-26 — Notice of proposed sale filed (Form 144)
• 2026-06-10 — Employee-plan registration (S-8) filed
• 2026-06-02 — Insider transaction reported (Form 4)
• 2026-06-01 — Insider transaction reported (Form 4)
• 2026-06-01 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ACADIA PHARMACEUTICALS INC COM has 339 institutional holders and institutional ownership of 96.2%.

Insider activity

Insiders reported 49 transactions (0 buys, 24 sells) across 12 reporting insiders, with a net reported value of −$3.04M.

Related companies

LIVANOVA PLC SHS (LIVN) · EDGEWISE THERAPEUTICS INC (EWTX) · CRISPR THERAPEUTICS AG (CRSP) · TWIST BIOSCIENCE CORP (TWST) · TRANSMEDICS GROUP INC (TMDX) · TG THERAPEUTICS INC (TGTX)